Puglisi, Fabio http://orcid.org/0000-0003-0573-4938
Gerratana, Lorenzo
Lambertini, Matteo http://orcid.org/0000-0003-1797-5296
Ceppi, Marcello
Boni, Luca http://orcid.org/0000-0003-2217-4047
Montemurro, Filippo http://orcid.org/0000-0003-4231-2291
Russo, Stefania
Bighin, Claudia
De Laurentiis, Michelino
Giuliano, Mario
Bisagni, Giancarlo
Durando, Antonio
Turletti, Anna
Garrone, Ornella
Ardizzoni, Andrea
Gamucci, Teresa
Colantuoni, Giuseppe
Gravina, Adriano
De Placido, Sabino
Cognetti, Francesco
Del Mastro, Lucia http://orcid.org/0000-0002-9546-5841
Article History
Received: 20 August 2020
Accepted: 27 May 2021
First Online: 28 June 2021
Competing interests
: F.P. reports research grant/funding from AstraZeneca, Eisai, personal fees from AstraZeneca, Roche, Amgen, Lilly, Novartis, Pfizer, outside the submitted work; L.G. reports non-financial support from Menarini Silicon Biosystems, personal fees from Lilly, outside the submitted work; M.L. reports personal fees from Roche, Takeda, Theramex, Lilly, Pfizer, outside the submitted work; F.M. reports personal fees from Roche, Lilly, Novartis, Pfizer, Pierre Fabre, Daiichi Sankyo, outside the submitted work; C.B. reports research grant/funding from Roche, Novartis, personal fees from Roche, Novartis, Lilly, outside the submitted work; M.D.L. reports personal fees from Novartis, Pfizer, AstraZeneca, Roche, Pierre Fabre, Amgen, Lilly, MSD, Celgene, Eisai, outside the submitted work; M.G. reports reports non-financial support from Roche, Pfizer, Novartis, Amgen, personal fees from Novartis, Lilly, Pfizer, Eisai, Celgene, AstraZeneca, Roche, outside the submitted work; A.T. reports personal fees from Eisai, Roche, Pfizer, outside the submitted work; O.G. reports personal fees from Pfizer, Novartis, Eisai, Lilly, non-financial support from Roche, outside the submitted work; T.G. reports non-financial support from Pfizer, Novartis, Roche, Lilly, personal fees from Eisai, Pfizer, Novartis, Roche, Lilly, outside the submitted work; G.T. research grant/funding from Roche, Novartis, personal fees from Roche, Novartis, outside the submitted work; A.G. reports non-financial support from Pfizer, personal fees from Istituto Gentili, outside the submitted work; S.D.P. reports personal fees from GSK, Novartis, Roche, Celgene, AstraZeneca, Amgen, Teva,Eisai, Pfizer, Lilly, outside the submitted work; C.F. reports non-financial support from Novartis, Roche, MSD, BMS, personal fees from ABBOTT, CELGENE, GSK, Roche, Bayer, Novartis, Amgen, Pfizer, AstraZeneca, EISAI, Vifor Pharma, Merck—Serono, Boheringer Ingelheim, MSD, BMS, Takeda, Astellas Oncology, Lilly, Genomic Health, outside the submitted work; L.D.M. reports non-financial support from Roche, Celgene, Pfizer, personal fees from Genomic Health, Pfizer, Seattle Genetics, Pierre Fabre, Lilly, Roche, Novartis, MSD, Eisai, Ipsen, Takeda, outside the submitted work. The remaining authors declare no competing interests.